C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof

Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
11/2001
11/20/2001	US6320035 C-nucleoside derivatives and their use in the detection of nucleic acids
11/20/2001	US6319908 Method for large-scale production of di(uridine 5′-tetraphosphate) and salts thereof
11/20/2001	US6319711 Composition and method for inhibiting reverse transcript of a retrovirus
11/20/2001	US6319695 Production of fucosylated carbohydrates by enzymatic fucosylation synthesis of sugar nucleotides; and in situ regeneration of GDP-fucose
11/15/2001	WO2001085751A1 Polymeric compounds useful as prodrugs
11/15/2001	WO2001085750A1 Uridine derivatives as antibiotics
11/15/2001	WO2001085749A1 Anti-viral pyrimidine nucleoside analogues
11/15/2001	WO2001085165A2 Combination of lipoic acid and c1 donors for the treatment of disorders of the central nervous system
11/15/2001	WO2001016150A3 Nucleoside analogues
11/15/2001	WO2001007088A3 Methods for treating therapy-resistant tumors
11/15/2001	WO2000064484A3 Conjugate having a cleavable linkage for use in a liposome
11/15/2001	US20010041794 Nucleotide analogs
11/15/2001	US20010041689 Bisphosphonate conjugates and methods of making and using the same
11/15/2001	US20010041682 Purine or pyrimidine containing dinucleotide derivatives useful for hydrating mucous secretions in the lungs of a patient in need of such a treatment
11/15/2001	US20010041346 Complex of cyclic guanosine monophosphate protein kinase and myosin phosphatase
11/15/2001	DE10022856A1 Treating central nervous system disorders e.g. cognitive deficiency or depression, using combination of lipoic acid and C-1 donor e.g. S-adenosyl-methionine
11/15/2001	CA2408666A1 Combination of lipoic acid and c1 donors for the treatment of disorders of the central nervous system
11/15/2001	CA2408453A1 Uridine derivatives as antibiotics
11/15/2001	CA2406633A1 Anti-viral pyrimidine nucleoside analogues
11/14/2001	EP0850246B1 Pyrimidine nucleoside derivatives
11/14/2001	EP0817790B1 Specific lipid conjugates of nucleoside diphosphates and their use as drugs
11/13/2001	US6316610 Hybrid stabilization
11/13/2001	US6316426 Nucleoside derivative for diabetes, heart disease, cerebrovascular disorders, parkinson's disease, infant respiratory distress syndrome and for enhancement of phospholipid biosynthesis
11/13/2001	US6316425 Therapeutic agents
11/13/2001	US6316418 Regulated apoptosis
11/08/2001	WO2001084234A1 Method for immobilizing oligonucleotides employing the cycloaddition bioconjugation method
11/08/2001	WO2001083502A1 Tag library compounds, compositions, kits and methods of use
11/08/2001	WO2001083501A1 Anti-viral pyrimidine nucleoside analogues
11/08/2001	WO2001083500A1 13-substituted milbemycin derivatives, their preparation and their use against insects and other pests
11/08/2001	WO2001082965A1 Combination therapy of respiratory diseases using antibodies
11/08/2001	WO2001058920A3 Process for selectively producing 1-phosphorylated sugar derivative anomer and process for producing nucleoside
11/08/2001	WO2000066607A9 Detection using degradation of a tagged sequence
11/08/2001	WO1999051621A3 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
11/08/2001	US20010039342 Chemical intermediate for stavudine
11/08/2001	US20010039011 Complexing; biosynthesis
11/08/2001	EP1144429A3 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
11/08/2001	CA2409689A1 Combination therapy of respiratory diseases using antibodies
11/08/2001	CA2407611A1 13-substituted milbemycin derivatives, their preparation and their use against insects and other pests
11/07/2001	EP1152010A2 Oligonucleotide labeling reactants and their use
11/07/2001	EP1152009A1 Novel nucleosides and oligonucleotide analogues
11/07/2001	EP1152008A2 Fluorescent nucleotides containing a cyanine, merocyanine or styryl dye for the detection of nucleic acid
11/07/2001	EP1151350A1 Protecting groups with increased photosensitivities
11/07/2001	EP1151130A1 Coenzymes useful for the synthesis of l-carnitine
11/07/2001	EP1150991A2 Compositions for treating inflammatory response
11/07/2001	CN1321163A Crystal of diuridine tetraphosphate or salt thereof and method for preparing same, and method for producing said compound
11/07/2001	CN1320706A Method for preparing guanosines compounds and its intermidiates
11/06/2001	US6313286 Nucleoside analogues
11/06/2001	US6312897 Template-directed interference footprinting of protein-adenine contacts
11/06/2001	US6312894 Hybridization of oligonucleotides and minor groove binder combination; where the minor groove binder binds in a non-intercalating manner with a higher association constant
11/06/2001	US6312662 Prodrugs phosphorus-containing compounds
11/06/2001	CA2214535C Improved process for the synthesis of 2'-o-substituted pyrimidines and oligomeric compounds therefrom
11/01/2001	WO2001081360A1 Novel, photo-labile cumarinylmethyl esters of cyclic nucleotides, method for the production and use thereof
11/01/2001	WO2001081359A1 Ribavirin-interferon alfa combination therapy for eradicating detectable hcv-rna in patients having chronic hepatitis c infection
11/01/2001	WO2001060381B1 Nucleoside analogs with carboxamidine-modified bicyclic base
11/01/2001	US20010036930 Therapeutic azide compounds
11/01/2001	US20010036923 Complex
11/01/2001	US20010036629 Sequencing of surface immobilized polymers utilizing microfluorescence detection
11/01/2001	US20010036500 For enriching foods or beverages, anemia treatment
10/2001
10/31/2001	EP1040116A4 Functionalized pyrimidine derivatives
10/31/2001	DE10021256A1 Neue, photolabile Cumarinylmethylester von cyclischen Nucleotiden, Verfahren zu deren Herstellung und ihre Verwendung New photolabile coumarinylmethyl esters of cyclic nucleotides, processes for their preparation and their use
10/31/2001	CN1320128A Beta-L-2-deoxy-nucleosides for the treatment of hepatitis B
10/30/2001	US6310189 Nucleotides and analogs having photoremoveable protecting groups
10/30/2001	US6309892 Detecting immunoglobulins in sample; incubate sample with dense microspheres, monitor and measure immune reponse
10/30/2001	US6309836 Contacting target nucleic acid with primer so primer anneals to nucleic acid in sequence specific manner, incorporating hydrocarbyldithiomethyl-modified nucleotide into primer, detecting modified nucleotide, identifying sequence of base
10/30/2001	US6309822 Detecting adjustments in nucleotide sequences; provide probes, mix probes with nucleic acids, detect binding of probes to preferential nucleotide sequences
10/25/2001	WO2001079248A1 Process for the preparation of cytidine derivatives
10/25/2001	WO2001079246A2 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections
10/25/2001	WO2001078749A1 Novel calcium antagonists
10/25/2001	WO2001006986A3 5-(e)-bromovinyl uracil analogues and related pyrimidine nucleosides as anti-viral agents and methods of use
10/25/2001	WO2000053812A9 Replica amplification of nucleic acid arrays
10/25/2001	WO2000040605A9 Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids
10/25/2001	US20010034440 Complexing the target cell with therapeutic agent; antiproliferative agent
10/25/2001	US20010034048 Complementary to a target polynucleotide sequence by hybridizing a single stranded DNA target template with a composite primer comprising an RNA protion and a 3'DNA portion; extending with a polymerase; cleaving the RNA
10/25/2001	US20010034047 Reacting glyoxal-guanine with ribose-1-phosphate or 2-deoxyribose-1-phosphate in the presence of purine nucleoside phosphorylase; decomposition with an alkali to produce guanosine or 2*-deoxyguanosine; efficiency
10/25/2001	US20010033972 Comprises nonaqueous electrolytic solution and current collector coated with active material and immersed in electrolytic solution; lightweight, useful for electric hybrid vehicles
10/25/2001	US20010033862 Methods of treating viral infections using antiviral liponucleotides
10/25/2001	CA2404639A1 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections
10/24/2001	EP1147119A1 2,3-o-isoproylidene derivatives of monosaccharides as cell adhesion inhibitors
10/24/2001	EP0948514A4 Method for the synthesis of nucleotide or oligonucleotide phosphoramidites
10/23/2001	US6307043 For treatment or prophylaxis of herpes viral infections
10/23/2001	US6307040 Sugar modified oligonucleotides that detect and modulate gene expression
10/23/2001	US6306834 Methods of treating or preventing radiation, mutagen and sunlight-induced biological damage, methods for improving wound healing and tissue repair, comprising administering the compositions of the present invention to an animal.
10/23/2001	US6306607 Heterogeneous assay for pyrophosphate
10/23/2001	CA2037411C Milbemycin ether derivatives
10/18/2001	WO2001077103A1 Process for preparing 5'-acetylstavudine
10/18/2001	WO2001077083A1 Process for preparing substituted benzimidazole compounds
10/18/2001	WO2001077075A2 Inhibitors of inflammation and reperfusion injury
10/18/2001	WO2001039724A3 Phosphonate compounds
10/18/2001	WO2000056746A3 Improved synthesis of [2.2.1]bicyclo nucleosides
10/18/2001	US20010031743 Vision defects
10/17/2001	EP1144430A1 Protecting groups for carbohydrate synthesis
10/17/2001	EP1144429A2 Hybridization and mismatch discrimination using oligonucleotides conjugated to minor groove binders
10/17/2001	EP1144414A2 Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids
10/17/2001	EP1143991A2 Inhibitors of h+k+ -atpase
10/17/2001	EP1143974A1 Pharmaceutical compositions for alleviating discomfort
10/17/2001	EP0901501B1 Nucleoside derivatives with photo-unstable protective groups
10/17/2001	EP0842185B1 Ara-c derivatives
10/16/2001	US6303775 Polynucleotides labelled with asymmetric benzoxanthene dyes
10/16/2001	US6303774 Antiviral agents, anticancer agents, metabolic moderators
10/11/2001	WO2001075139A1 Reversible chemical modification of nucleic acids and improved method for nucleic acid hybridization

1 ... 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 ... 201